Category Archives: Research

20May/21

Reinventing the Value Network with the Factory of the Future

The factory of the future goes beyond the traditional factory walls

By: Sandra K. Rodriguez, Senior Industry Analyst

The need for organizational visibility, control, and resilience has never been greater for the life sciences industry. Executives at forward-thinking companies are addressing the need to solve both present and future challenges. The increasing complexity of designing, sourcing, and manufacturing high-quality medical products under stringent regulations requires a digital factory that supports closed loop manufacturing across-the-product lifecycle. In short, a sustainable factory of the future is needed now.

The factory of the future goes beyond traditional factory walls; it requires digital transformation across the entire medical product value network. Axendia research indicates that 76 percent of digital transformation initiatives are being accelerated by “black swan” events. Digital transformation is a journey, not a project. Life science organizations that have embarked on this journey are modernizing manufacturing and reinventing their value networks.

Building the Factory of The Future, Today

Delivering high-quality, next-generation life-science products is not easy. Stakeholders expect high-quality, complex products manufactured sustainably under stringent regulations. The factory of the future supports closed loop manufacturing and workforce optimization by connecting the following technologies across the total product lifecycle:

  • Product Lifecycle Management
  • Enterprise Resource Planning
  • Manufacturing Operations Management (MOM)
  • Advanced Planning and Scheduling (APS)
  • Modeling and Simulation

Read the entire article in Medical Product Outsourcing

Register to receive your complimentary copy of our Voice of the Customer eBook, presented by Dassault Systèmes: The Life-Science Factory of the Future

Webinar available on-demand: Building the Factory of the Future, Today

14Apr/21

Q: Who is the Best Technology Vendor? A: NONE!

An open Letter to the Life-Sciences Industry on Analyst Forced Vendor Rankings

By: Daniel R. Matlis

As a Life-Science Industry Analyst, I am often asked by executives to recommend the best technology vendor.

My standard answer:  None, there is no such thing as a “best vendor.”   

Just like an automotive industry analyst could not recommend the “best car” for you until they know your budget, unique requirements, and primary use; a Life Science industry analyst must understand your company’s intended use, business, regulatory and technology requirements, as well as organizational culture before recommending a system.

Yet for decades, Life-Science industry executives have relied on forced rankings from analyst firms to identify the top five vendors to invite for an RFP.  This is especially true when evaluating the alphabet soup of system acronyms (AI/ML, APS, CTMS, CM&S, EAM, EDC, ERP, LIMS, MES, PLM, RIM, SCM, etc., etc., etc.)

Continue reading
05Feb/21

2021 Forecast for the Life-Sciences Industry

Industry must adapt and overcome current and future disruptive trends on the horizon. To assist in this effort, Axendia revealed the 2021 Life-Sciences Radar.

In this episode of Straight from the Source, Axendia’s President and Founder, Daniel R. Matlis and Sandra K. Rodriguez, Market Analyst discuss how major disruptions in 2020 have accelerated key modernization initiatives to support resilience through the Life-Science value network.  They also address the need for interdependence across these transformational initiatives to overcome business, regulatory, technology and cultural inertia and plot a course to success.

27Oct/20

eBook: Are You on the Right Side of the Digital Divide?

An Axendia Voice of the Customer eBook, Presented by Propel

By: Sandra K. Rodriguez, Market Analyst

Historically, Life-Science companies have implemented on-premise electronic quality management systems (QMS) to support regulatory requirements and to replace paper-based processes. Likewise, product lifecycle management (PLM) processes were often paper-based or in stand-alone systems disconnected from QMS, field service management and customer relationship management (CRM). With the advent of the cloud, organizations began leveraging the ability to integrate and access product, quality and customer information from anywhere, on any device, at any time in a secure and controlled manner.  

In this Voice of the Customer eBook, presented by Propel, we address how cloud-based digital solutions are enabling the unification of processes and data that once resided in outdated, disparate and disconnected legacy systems.  By taking a common platform approach, Life-Science companies are transforming and simplifying business processes in the cloud, driving organizational efficiencies in a compliant and cost-effective manner, and delivering greater customer satisfaction through it all.  

In this eBook, executives from Advanced Sterilization Products (ASP) and Cantel discuss:

  • The Value of an Integrated Platform
  • Getting Cloud Comfortable in a Regulated Environment
  • Faster Time to Value
  • Streamlined Compliance with Global Regulatory Requirements
  • Unlocking the Value of a Platform
  • Why Data Integrity is Business Integrity
  • The Benefits of a Closed-Loop Platform
  • Pros, Cons and Lessons Learned

To determine if your organization is on the right side of the digital divide, request your copy below.

09Jun/20

eBook: Digital Transformation and Manufacturing Mondernization

Is The Gain Worth The Pain?

By: Sandra K. Rodriguez, Market Analyst

Pharmaceutical organizations are continuously seeking to implement mature manufacturing technologies to ensure the availability of products for their patients.  Unfortunately, once a facility has been approved for manufacturing by regulators, it is often frozen in time for decades.   This has been one of the unintended consequences of regulatory enforcement and has led to the slow uptake of modernization and digital transformation in Pharma.  

Pharmaceutical business models are changing, and supply chains have become tightly integrated supply networks.  In addition, regulatory agencies, although often seen as the industry’s biggest business disruptori, are actually encouraging innovation in manufacturing.  Life-Science companies are cloud curious and most are in the pilot phase of implementing emerging technologies such as Artificial Intelligence (AI), Machine Learning (ML), Augmented Reality (AR) and Virtual Reality (VR).   

Based on Axendia’s primary research and interviews with executives on the adoption of modernization and digital transformation in the Life-Science industry, we determined that digital transformation and modernizing manufacturing often do not go hand in hand.  In fact, through our discussions and interactions with industry executives for this report, we quickly determined that digital transformation and modernizing manufacturing are not synonymous and often take different paths.    

Continue reading